Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      1. Latvia/
      2. About Us
      JJIM Images/JJ_Photo_CorkFacility_1879.jpg

      About us

      Advancing science for the benefit of patients
      We are looking at a future where the world of healthcare will be challenged by informed and empowered patients. We work for change that will improve access to medicines : the best available treatment at an affordable price. That’s why we at Janssen strive to provide access to effective and affordable medicines and related health care services to the people who need them.


      Partnering with academic researchers around the world, we bring innovative therapeutic solutions to key unmet needs. Our approach seeks to combine complementary skills. Building strong working partnerships with governments, patient groups, healthcare professionals, and other professionals from the global academic and business communities.

      Our mission is to make the most fundamental change in the way diseases are managed. We have a leading portfolio of solutions that can alleviate, contain or cure some of the world’s most serious conditions and diseases.

      But we go one step further in our commitment. We are building great healthcare solutions that will bring benefits to patients and add value to society and our company’s stakeholders. We want to develop innovative and integrated products and medicines to restore and extend the quality of life. We also want to provide a return on investment that reflects outstanding performance and to reward those who invest ideas and work in our company.

      To ensure that we can deliver our commitments to patients, customers and investors who rely on us, we work side-by-side with healthcare stakeholders and build on our people’s talent. Together, we are looking at a future where patients and their families have a new sense of hope. Hope for a cure.
      Our mission is to transform individual lives
      We are actively developing treatments for our patients in five important therapeutic areas of healthcare :
      Quick facts about Janssen
      Janssen is a worldwide group of pharmaceutical companies:
      • Part of Johnson & Johnson, the USA based Healthcare Corporation
      • 40,000 employees working across the five continents
      • Around $4.5 billion investments in research & development annually
      • A top 10 company in the global pharmaceutical sales
      Janssen in Europe, the Middle East & Africa (EMEA) has:
      • Activities in more than 100 countries
      • Local offices in more than 30 countries
      • More than 14,000 employees
      • Research & Development investments of more than €1.5 billion annually
      We have 8 research & development centres in EMEA:
      • Beerse in Belgium
      • High Wycombe in the UK
      • Leiden (Janssen Biologics) in The Netherlands
      • Val-de-Reuil in France
      • Schaffhausen and Bern (Janssen Vaccines AG) in Switzerland
      • Toledo in Spain
      In EMEA, we have 9 manufacturing sites for worldwide distribution of medicines and vaccines:
      • Beerse, Geel and Olen in Belgium
      • Cork in Ireland
      • Latina in Italy
      • Leiden in The Netherlands
      • Schaffhausen and Bern (Crucell) in Switzerland
      As part of the Johnson & Johnson Family of Companies, the values that guide our decision-making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
      Contact us
      Sazinieties ar mums
      UAB “JOHNSON & JOHNSON” filiāle Latvijā
      101 Mūkusalas iela, LV-1004 Rīgā, Latvijā
      Tālr. +37167893561
      [email protected]
      Contact us
      UAB “JOHNSON & JOHNSON” Latvian branch
      Mūkusalas str. 101
      LV-1004 Riga, Latvia
      Tel +37167893561
      [email protected]